BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $11.35 billion as of May 19, 2025. Its market cap has decreased by -28.28% in one year.

Market Cap

11.35B

Enterprise Value

10.62B

1-Year Change

-28.28%

Ranking

#808

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $11.35B, an increase of 2,459.17%. That is a compound annual growth rate of 13.38%.

Market Cap History

Date	Market Cap	% Change
May 16, 2025	11.37B	-9.26%
Dec 31, 2024	12.53B	-31.03%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%
Dec 31, 2001	594.30M	67.03%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	679.94B
Johnson & Johnson	364.11B
AbbVie	325.05B
Novo Nordisk	282.81B
UnitedHealth Group	264.80B
Abbott Laboratories	234.53B
Novartis AG	213.43B
AstraZeneca	212.39B

Market Cap Rankings